Cytokinetics Statistics
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
50.78-0.68 (-1.32%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cytokinetics by the numbers
Cytokinetics has a market capitalization of $7.07 billion based on 139.30M shares outstanding. With trailing EPS of $-6.02, Cytokinetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.9% below its 50-day average and 26.9% below its 200-day average.
Average daily trading volume is 2.02M shares, or about $102.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CYTK valuation vs. peer median
| Metric | CYTK | Peer median | Difference |
|---|---|---|---|
| Market cap | $7.07B | $7.37B | -4% |
| Avg. volume | 2.02M | 1.18M | +71% |
Peer median across 8 companies: AMRX, CORT, KNSA, AXSM, ALKS, RYTM, PTGX, ABVX.
Valuation
- Market cap
- $7.07B
- Price / sales (latest FY)
- 80.35
- EPS (TTM)
- $-6.02
- Shares outstanding
- 139.30M
Price and trading
- Previous close
- 51.46
- Open
- 51.23
- Day range
- 50.60 – 53.38
- 52-week range
- 50.32 – 88.31
- 52-week change
- -22.40%
- Beta
- —
- Volume
- 1.43M
- Average volume
- 2.02M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 7.07B
- Forward Pe
- -12.03
- Eps
- -6.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 88.31
- Week52 Low
- 50.32
- Avg Volume
- 2.02M
- Shares Outstanding
- 139.30M
- Ma50
- 61.89
- Ma200
- 69.49
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -42.50%
- Pct From52w Low
- 0.91%